Niconex Medical Ltd | E-mail:info@niconmedical.com | Phone: +357 22 250804 | Office Hours: M-Fr 09:00-18:00

Niconex Medical Ltd – Regulatory Affairs and Pharmacovigilance Consulting Services

Niconex Medical is a new company providing expertise in local regulatory affairs, pharmacovigilance and medical affairs. The company understands clients’ requirements and engages to ensure high-quality results are delivered in a timely manner to maintain product safety and updated dossiers.


At Niconex Medical we provide local Regulatory Affairs and Pharmacovigilance services to support pharmaceutical companies in the registration and maintenance of medicinal products and medical devices in the Republic of Cyprus. In line with safety obligations, Niconex Medical offers local Pharmacovigilance representation for constant monitoring and safety reporting. Our consulting services include regulatory intelligence available on a regular basis or per request to support in advance planning and preparation aligned with National Competent Authority (NCA) requirements.

Local Regulatory Affairs in compliance with requirements to achieve high-quality results within stringent timelines.

Local Regulatory Affairs Affiliate Service

Niconex Medical acts as local Regulatory Affairs contact for all regulatory matters pertaining to partners’ products including preparation of local dossier, submission of applications e.g. new Marketing Authorization applications, Variations, Renewals, Responses to Questions, Post-Approval commitments e.t.c., align / validate local Product Information, translations, quality control of artworks, any follow-up actions or communications with local Health Authorities with regards to submissions, deficiencies and other national requests. Niconex Medical can support with regulatory intelligence to assist partners in planning and preparing in advance according to local regulations.

Read More

Local Pharmacovigilance services to constantly monitor and maintain safe products in accordance with regulations.

Local Pharmacovigilance Affiliate Service

Provision of local 24/7 responsible person for Pharmacovigilance in line with local requirements to monitor product safety at national level and maintain reporting in timely manner according to required deadlines. Niconex Medical also supports with submission of safety reports, Dear Healthcare Provider (DHCP) letter preparation, submission for approval and dissemination to concerned local parties. In addition, we provide quality control and approval of Educational and / or Promotional Material according to national requirements. If required, we additionally support with scientific and medical HCP communications or visits as partial fulfillment of local Medical Affairs or Medical Science Liaison (MSL) service.

Read More

Support with periodic queries or tasks related to Regulatory Affairs, Pharmacovigilance, Medical Affairs and Market Access.

Consulting Services

Individual services are provided to additionally support periodic requirements of local regulatory intelligence, local NCA fees information, pricing approvals, sales submissions, support with periodic reports, clinical / non-clinical overviews or any other ad hoc individual services e.g. per request DHCP letters, additional document submissions or regulatory reviews and translation services of product texts, additional per request communications with local Authorities.

Read More

Go to article: Home | Invest in TechGo to article: In this issueGo to article: Gerteis Company InsightGo to article: GerteisGo to article: ContentsGo to article: DJAGo to article: NewsGo to article: MedelpharmGo to article: Biotech M&A: will the 2018 surge last?Go to article: NSFGo to article: Can the gene and cell therapy revolution scale up?Go to article: Haselmeier GmbH Company InsightGo to article: Haselmeier GmbH Go to article: Gut instinct: how common drugs affect the microbiomeGo to article: HOF Sonderanlagenbau Company InsightGo to article: HOF SonderanlagenbauGo to article: Tracing the story of mumps: a timelineGo to article: Molnar Company InsightGo to article: MolnarGo to article: Inside Swiss pharma: the ideal environment for successGo to article: Is the UK’s drug evaluation system in need of an overhaul?Go to article: Scandinavian Health Ltd. Company InsightGo to article: Scandinavian Health Ltd.Go to article: MoehsGo to article: Could digital tech unlock billions in savings for pharma companies?Go to article: EcocoolGo to article: CRISPR: a seismic shift in gene editingGo to article: Mestra AG (Endress + Hauser)Go to article: EventsGo to article: Pfanstiehl Inc Company InsightGo to article: Pfanstiehl Inc.Go to article: Next issueGo to article: Niconex Medical LtdGo to article: Alpex Pharma SAGo to article: Pall Biotech Company InsightGo to article: Pall BiotechGo to article: AtoZ-CRO GmbHGo to article: WIKA - Disaster preventionGo to article: Bea TechnologiesGo to article: BaxterGo to article: SuezGo to article: Raland Compliance Partners